Skip to content
Luas Diagnostics logo — Making diagnostic testing accessible for everyone.

Luas Diagnostics

Making diagnostic testing accessible for everyone.

Founded 2020 United Kingdom London, United Kingdom 2 employees Equity Crowdfunding Total: $332.96K Health Care

General Information

Company Name Luas Diagnostics
Founded Year 2020
Location United Kingdom London, United Kingdom
Employees 2
Industries Health Care
Funding Stage Equity Crowdfunding
Social

BounceWatch is an independent company data service, not affiliated with Luas Diagnostics. To contact Luas Diagnostics, visit luasdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Luas Diagnostics compare?

A PDF of Luas Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Luas Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Luas Diagnostics

Luas Diagnostics is a Health Care startup based in the United Kingdom, founded in 2020. The company's slogan "Making diagnostic testing accessible for everyone" reflects its mission to provide a range of best-in-class products for testing infectious diseases. These products, including a home-to-laboratory test for Group B Streptococcus (www.strepelle.com) and self tests for HIV, Step A, CRP, UTI's and PSA, are designed to be easy to use both at home and at the Point-Of-Care.

The company recently secured a £9.08K Equity Crowdfunding investment on 05 November 2021, with Crowdcube as the investor. This indicates an early interest and support for Luas Diagnostics' innovative approach to making diagnostic testing more accessible.

Business keywords: Diagnostics, Point-Of-Care Testing, Home Testing, Infectious Diseases, Therapeutic Drug Monitoring, Covid-19 Testing, Group B Streptococcus, HIV Testing, UTI Testing, CRP Testing, Strep A Testing, PSA Testing

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding £9.08K 1
Crowdcube
05 Nov 2021
Equity Crowdfunding £323.88K 1
Crowdcube
06 Nov 2020

Luas Diagnostics Alternatives & Competitors

View All Alternatives
Luas Diagnostics vs
Senzo Health
Senzo Health United States

PCR-Accurate Lateral Flow Testing

8 employees
Biotechnology, Health Care
Luas Diagnostics vs
Revlar Diagnostics
Revlar Diagnostics United States

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and...

4 employees
Biotechnology, Health Care
Luas Diagnostics vs

Providing genetic and molecular diagnostic solutions to advance healthcare.

5 employees
Health Care

FAQ About Luas Diagnostics

Making diagnostic testing accessible for everyone.
Luas Diagnostics was founded in 2020.
Luas Diagnostics is headquartered in London, United Kingdom.
Luas Diagnostics operates in Health Care. Its work centres on Diagnostics, Point-Of-Care Testing, Home Testing and Infectious Diseases.
Luas Diagnostics has approximately 2 employees.
Luas Diagnostics has completed 2 funding rounds, raising a total of $332.96K. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to Luas Diagnostics include Senzo Health, Revlar Diagnostics, RESOLVE MOLECULAR DIAGNOSTICS LLC, EKF Diagnostics, Aidian. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Luas Diagnostics and Senzo Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Luas Diagnostics, https://bouncewatch.com/company/luas-diagnostics, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout